N'-hydroxy-N-(4-propylphenyl)formimidamide

ID: ALA5274795

Chembl Id: CHEMBL5274795

Max Phase: Preclinical

Molecular Formula: C10H14N2O

Molecular Weight: 178.24

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCc1ccc(N/C=N/O)cc1

Standard InChI:  InChI=1S/C10H14N2O/c1-2-3-9-4-6-10(7-5-9)11-8-12-13/h4-8,13H,2-3H2,1H3,(H,11,12)

Standard InChI Key:  HMPRMXLNQCPSPS-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5274795

    ---

Associated Targets(Human)

CYP4Z1 Tchem Cytochrome P450 4Z1 (127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 178.24Molecular Weight (Monoisotopic): 178.1106AlogP: 2.47#Rotatable Bonds: 4
Polar Surface Area: 44.62Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.66CX Basic pKa: 2.43CX LogP: 2.57CX LogD: 2.57
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.32Np Likeness Score: -0.66

References

1. Yuan Y, Yao H, Zhou M, Ma X, Zhou Y, Xu J, Niu M, Yin J, Zheng L, Xu S..  (2022)  Identification of a Novel Potent CYP4Z1 Inhibitor Attenuating the Stemness of Breast Cancer Cells through Lead Optimization.,  65  (23.0): [PMID:36414390] [10.1021/acs.jmedchem.2c01320]

Source